Torres PML

Language: Spanish
References: 10
Page: 215-220
PDF size: 45.36 Kb.

ABSTRACT

Pharmacological therapeutics in acute myocardial infarction. The acute myocardial infarct is one of the main causes of death among the adult population of the industrialized countries, and this pattern is starting to be paralleled in many developing countries. The mortality rate due to coronary diseases has decreased 30% in the last decade, thanks to the new therapeutic strategies and the guidelines developed by the American college of Cardiology and the American Heart Association, aimed at physicians, nurses, and health personnel in charge of patients with suspected myocardual infarct or with an established myocardial infarct. These guidelines and strategies explain the fundaments of the administration of thrombolytic agents, coronary angioplasty, surgery, and the use of betablockers, platelet antiaggregating agents and angiotensin-converting enzyme inhibitors. These recommendations are followed at the Coronary Intensive Care Unit of the National Institute of Cardiology “Ignacio Chávez”, and therefore it was necessary to perform this bibliographic review to continue with the safety standards established for the follow-up protocols of the ischemic patient, aimed at assessing their efficacy and efficiency.

REFERENCES

1. Grupo Italiano per lo Studio de la Streptochinasi nell’ Infarto Miocárdico (GISSI). Effectiveness of intravenous trombolytic treatmen in acute myocardial infarction. Lancet 1986; 1: 397-402.

2. WINSLOW EH: Cardiovascular consequences of bed rest. Heart Lung 1985; 14: 236-246.

3. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction: Gruppo Italiano pero lo Studio della Sopravivencia nell’ Infarto Miocardico. Lancet 1994; 343: 1115-1122.

4. BALVANERA A, MARTÍNEZ G, GASPAR J: Angioplastía primaria en el tratamiento del infarto agudo del miocardio. Am Med Asoc Med Hosp ABC México, 1997; 42 (3): 105-110.

5. CANOBBIO MM: Trastornos cardiovasculares. Ed Doyma, S.A. 1993; 309.

6. LEIVA PJ, ET AL: Manual de urgencias cardiovasculares. México, Ed. Interamericana, 1996; 507.

7. Fourth American College of Chest Physicians: Consensus Conferencce on Antithrombotic Therapy. Chest 1995; 180(suppl): 225S-522S.

8. FUNG HL, CHUNG SJ, BAUER JA, CHONG S, KOWALUK EA: Biochemical mechanism of organic nitrate action. Am J Cardiol 1992; 70(suppl 5): 4B-10B.

9. ARSENIAN MA: Magnesium and cardiovascular disease. Prog Cardiovasc Dis 1993; 35: 271-310.

10. MEAMAHON S, COLLINS R, PETO R, KOSTER RW, YUSUF S: Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988; 260: 1910-1916.